Mid-term treatment-related cognitive sequelae in glioma patients.

ABSTRACT:

Purpose

Cognitive functioning represents an essential determinant of quality of life. Since significant advances in neuro-oncological treatment have led to prolonged survival it is important to reliably identify possible treatment-related neurocognitive dysfunction in brain tumor patients. Therefore, the present study specifically evaluates the effects of standard treatment modalities on neurocognitive functions in glioma patients within two years after surgery.

Methods

Eighty-six patients with World Health Organization (WHO) grade 1-4 gliomas were treated between 2004 and 2012 and prospectively followed within the German Glioma Network. They received serial neuropsychological assessment of attention, memory and executive functions using the computer-based test battery Neuro

SUBMITTER: Schlomer S 

PROVIDER: S-EPMC9325813 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature